Anagrelide hydrochloride and Emicizumab-kxwh Subcutaneous
Determining the interaction of Anagrelide hydrochloride and Emicizumab-kxwh Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: anagrelide
Brand name: Agrylin
Synonyms: Anagrelide
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Anagrelide hydrochloride-Emla
- Anagrelide hydrochloride-Emla Topical
- Anagrelide hydrochloride-Emo-Cort Scalp Solution Topical application
- Anagrelide hydrochloride-Emo-Cort Topical application
- Anagrelide hydrochloride-Emoquette
- Anagrelide hydrochloride-Empagliflozin
- Emicizumab-kxwh Subcutaneous-Anakinra
- Emicizumab-kxwh Subcutaneous-Anakinra Subcutaneous
- Emicizumab-kxwh Subcutaneous-Analgesic Balm Greaseless
- Emicizumab-kxwh Subcutaneous-Analpram Advanced
- Emicizumab-kxwh Subcutaneous-Analpram E
- Emicizumab-kxwh Subcutaneous-Analpram E Cream